Septal myectomy in hypertrophic obstructive cardiomyopathy: late results with stress echocardiography

Ann Thorac Surg. 1997 Sep;64(3):739-45. doi: 10.1016/s0003-4975(97)00633-4.

Abstract

Background: This study was performed to assess the functional capacity of the survivors of septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy in long-term follow-up as assessed by dobutamine stress echocardiography.

Methods: Sixty-nine patients with hypertrophic obstructive cardiomyopathy underwent septal myectomy between 1975 and 1996. The mean age was 25.4 +/- 13.6 years (range, 6-58 years), and 10 of the patients were women. The early mortality was 4.3%. Hospital survivors (95.7%) were followed up for a mean of 43.8 +/- 28.7 months (range, 6-114 months).

Results: The postoperative mean functional capacity of the group was 1.47 +/- 0.56. No late deaths were reported. Forty-nine patients (74.2%) were evaluated with standard echocardiographic techniques, and 29 (43.9%) patients underwent dobutamine stress echocardiography. There was a significant decrease in the thickness of the interventricular septum after surgery. The mean preoperative and postoperative septal thickness was 1.99 +/- 0.59 cm (range, 1.3-3.8 cm) and 1.55 +/- 0.41 cm (range, 0.96-2.8 cm), respectively (p < 0.004). The mean posterior wall thickness was significantly less than the preoperative value (p = 0.008) and the left ventricular end-diastolic diameter was slightly greater in the postoperative measurements, but the difference was not significant (p = 0.162). Postoperative left ventricular outflow systolic gradients were reduced significantly when compared with preoperative values (preoperative mean, 78.4 +/- 33.6 mm Hg, range, 50-212 mm Hg versus postoperative mean, 17.9 +/- 15.9 mm Hg: range, 0-40 mm Hg; p < 0.0001).

Conclusion: Septal myectomy for patients with hypertrophic obstructive cardiomyopathy is a safe procedure with excellent clinical and functional results in the long-term follow-up.

Publication types

  • Comparative Study

MeSH terms

  • Actuarial Analysis
  • Adolescent
  • Adrenergic beta-Agonists*
  • Adult
  • Aortic Valve / abnormalities
  • Aortic Valve / surgery
  • Cardiomyopathy, Hypertrophic / diagnostic imaging
  • Cardiomyopathy, Hypertrophic / physiopathology
  • Cardiomyopathy, Hypertrophic / surgery*
  • Child
  • Dobutamine*
  • Echocardiography*
  • Echocardiography, Doppler
  • Female
  • Follow-Up Studies
  • Heart / physiopathology
  • Heart Septum / diagnostic imaging
  • Heart Septum / surgery*
  • Heart Ventricles / diagnostic imaging
  • Heart Ventricles / surgery
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Mitral Valve / surgery
  • Safety
  • Stroke Volume
  • Survival Rate
  • Systole
  • Ventricular Function, Left
  • Ventricular Outflow Obstruction / surgery

Substances

  • Adrenergic beta-Agonists
  • Dobutamine